Explore more
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) shares were up 3.9% during trading on Friday after Stifel Nicolaus ...
We recently published a list of 10 Stocks Outperform Broader Market Last Week. In this article, we are going to take a look ...
Shares of the Redwood City-based Soleno Therapeutics climbed 38% — the biggest one-day gain since September 2023 — to their ...
Investor's Business Daily on MSN3d
Soleno Surges Into Breakout On Hard-Won Obesity-Tied Approval, But Aardvark Reverses LowerSoleno Therapeutics won approval for a drug that treats excessive hunger associated with a rare disease, and the biotech ...
Soleno Therapeutics stock has surged over 1,500% since September 2023, driven by the progress and today's FDA approval of ...
GlobalData on MSN3d
Soleno wins FDA approval for Prader-Willi hyperphagia treatmentSoleno Therapeutics has won US Food and Drug Administration (FDA) approval for diazoxide choline – which will be branded as ...
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) had its price target upped by stock analysts at Laidlaw from $75.00 to ...
The FDA Wednesday approved the first drug to treat people with Prader-Willi syndrome, a rare genetic disease that causes an ...
We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a ...
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback